Abstract
Skin cancer is the most common malignancy in the Caucasian population in the Western world. The incidence of the three major types of skin cancer - basal cell carcinoma, squamous cell carcinoma and malignant melanoma - continues to increase. Skin cancers are broadly divided into melanoma and nonmelanoma skin cancers. Melanoma accounts for 4% of all skin cancers however it is responsible for 80% of deaths from skin cancer. Non melanoma skin cancers are locally destructive and the expense of their removal is a significant economic burden to the healthcare system. Individual risk for skin cancer is due to a combination of risk factors. Well known risk factors include ultraviolet exposure and skin type. In transplant patients immunosuppression plays a major role and squamous cell carcinoma is an important cause of mortality in this group. In the following chapter the relevance of folate metabolism and skin cancer is discussed including our recent findings on the folate metabolic pathway and squamous cell carcinoma in renal transplant patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 8-MOP:
-
8-methoxypsoralen
- AK:
-
Actinic keratosis
- BCC:
-
Basal cell carcinoma
- CT:
-
Heterozygotes
- DNA:
-
Deoxyribonucleic acid
- EBV:
-
Epstein-Barr virus
- ECP:
-
Extracorporeal photopheresis
- GvHD:
-
Graft-versus-host disease
- HPV:
-
Human papilloma virus
- MGMT:
-
Methyl guanine DNA methyltransferase
- MTHFR:
-
Methylenetetrahydrofolate reductase
- NMSC:
-
Non-melanoma skin cancer
- NTD:
-
Neural tube defects
- RTR:
-
Renal transplant recipients
- SAM:
-
S-adenosyl-l-methionine
- SCC:
-
Squamous cell carcinoma
- SNP:
-
Single nucleotide polymorphism
- TMECG:
-
Trimethoxybenzoyl-(-)-epicatechin
- UVA:
-
Ultraviolet A
- UVB:
-
Ultraviolet B
- UVR:
-
Ultraviolet radiation
References
Bjorkegren, K. and Svardsudd, K., 2003. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population-based study. Journal of Internal Medicine 254, 343–352.
Black, H.S., Herd, J.A., Goldberg, L.H., Wolf, J.E. Jr, Thornby, J.I., Rosen, T., Bruce, S., Tschen, J.A., Foreyt, J.P., Scott, L.W., Jaax, S. and Andrews, K., 1994. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine 330, 1272–1275.
Bouwes Bavinck, J.N., Hardie, D.R., Green, A., Cutmore, S., MacNaught, A., O’Sullivan, B., Siskind, V., Van Der Woude, F.J. and Hardie, I.R., 1996. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 61, 715–721.
Branda, R.F. and Eaton, J.W., 1978. Skin color and nutrient photolysis: an evolutionary hypothesis. Science 201, 625–626.
Cohn, B.A., 2002. Sunlight, skin color, and folic acid. Journal of American Academy of Dermatology 46, 317–318.
Cole, B.F., Baron, J.A., Sandler, R.S., Haile, R.W., Ahnen, D.J., Bresalier, R.S., McKeown-Eyssen, G., Summers, R.W., Rothstein, R.I., Burke, C.A., Snover, D.C., Church, T.R., Allen, J.I., Robertson, D.J., Beck, G.J., Bond, J.H., Byers, T., Mandel, J.S., Mott, L.A., Pearson, L.H., Barry, E.L., Rees, J.R., Marcon, N., Saibil, F., Ueland, P.M., Greenberg, E.R. and Polyp Prevention Study Group, 2007. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Journal of the American Medical Association 297, 2351–2359.
Conway, K., Edmiston, S.N., Khondker, Z.S., Groben, P.A., Zhou, X., Chu, H., Kuan, P.F., Hao, H., Carson, C., Berwick, M., Olilla, D.W. and Thomas, N.E., 2011. NEDNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Research 24, 352–360.
Der-Petrossian, M., Födinger, M., Knobler, R., Hönigsmann, H. and Trautinger, F., 2007. Photodegradation of folic acid during extracorporeal photopheresis. The British Journal of Dermatology 156, 117–121.
Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Kluijtmans, L.A., Van den Heuvel, L.P. and Rozen, R., 1995. Candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10, 111–113.
Han, J., Colditz, G.A. and Hunter, D.J., 2007. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 28, 390–397.
Hughes, M.C., Williams, G.M., Fourtanier, A. and Green, A.C., 2009. Food intake, dietary patterns, and actinic keratoses of the skin: a longitudinal study. The American Journal of Clinical Nutrition 89, 1246–1255.
Jablonski, N.G., 1992. Sun, skin colour and spina bifida: an exploration of the relationship between ultraviolet light and neural tube defects. Proceedings of the Australasian Society for Human Biology 5, 455–462.
Jablonski, N.G., 1998. UV light induced neural tube defects in amphibian larvae and their implications for the evolution of melanized pigmentation and declines in amphibian populations. Journal of Herpetology 32, 455–457.
Jablonski, N.G., 1999. A possible link between neural tuble defects and ultraviolet light exposure. Medical Hypotheses 52, 581–582.
Kim, Y.I., 2004. Folate and DNA methylation: A mechanistic link between Folate Deficiency and Colorectal Cancer. Cancer Epidemiology and Biomarkers and Prevention 13, 511–519.
Kono, S. and Chen, K., 2005 Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Science 96, 535.
Laing, M.E., Cummins, R., O’Grady, A., O’Kelly, P., Kay, E.W. and Murphy, G.M., 2010. Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients. British Journal of Dermatology 163, 345–352.
Laing, M.E., Dicker, P., Moloney, F.J., Ho, W.L., Murphy, G.M., Conlon, P., Whitehead, A.S. and Shields, D.C., 2007. Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients. Transplantation 84, 113–136.
Laing, M.E., Moloney, F.J., Kay, E.W., Conlon, P. and Murphy, G.M., 2006. Malignant melanoma in renal transplant recipients. British Journal of Dermatology 155, 857.
Lapunzina, P., 1996. Ultraviolet light-related neural tube defects? American Journal of Medical Genetics 67, 106.
Malerba, M., Gisondi, P., Radaeli, A., Sala, R., Calzavara Pinton, P. and Girolomoni, G., 2006. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. British Journal of Dermatology 155, 1165–1169.
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A. and Ståhle-Bäckdahl, M., 2004. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. European Journal of Epidemiology19, 225–230.
Martinez, J.C., Otley, C.C., Stasko, T., Euvrard, S., Brown, C., Schanbacher, C.F., Weaver A.L. and Transplant-Skin Cancer Collaborative, 2003. Defining the clinical course of metastatic skin cancer in organ transplant recipients: A multicentre collaborative study. Archives of Dermatology 139, 301–306.
Moloney, F.J., Comber, H., O’Lorcain, P., O’Kelly, P., Conlon, P.J. and Murphy, G.M., 2006. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. British Journal of Dermatology 154, 498–504.
Off, M.K., Steindal, A.E., Porojnicu, A.C., Juzeniene, A., Vorobey, A., Johnsson, A. and Moan, J., 2005 Ultraviolet photodegradation of folic acid. Journal of Photochemistry and Photobiology B: Biology 80, 47–55.
Sánchez-del-Campo, L., Chazarra, S., Montenegro, M.F., Cabezas-Herrera, J. and Rodríguez-López, J.N., 2010. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(−)- epicatechin. Journal of Cellular Biochemistry 110, 1399–1409.
Schinke, C., Mo, Y., Yu, Y., Amiri, K., Sosman, J., Greally, J. and Verma, A., 2010. Aberrant DNA methylation in malignant melanoma. Melanoma Research 20, 253–265.
Shelnutt, K.P., Kauwell, G.P., Gregory, J.F., 3rd, Maneval, D.R., Quinlivan, E.P., Theriaque D.W., Henderson, G.N. and Bailey L.B., 2004. Methylenetetrahydrofolate reductase 677C → T polymorphism affects DNA methylation in response to controlled folate intake in young women. Journal of Nutritional Biochemistry 15, 554–560.
Stern, L.L., Mason, J.B., Selhub, J. and Choi, S.W., 2000. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiology, Biomarkers and Prevention 9, 849–853.
Suzuki, K., Suzuki, I., Leodolter, A., Alonso, S., Horiuchi, S., Yamashita, K. and Perucho, M., 2006. Global DNA demethylation in gastrointestinal cancer is age dependant and precedes genomic damage. Cancer Cell 3, 199–207.
Vanizor Kural, B., Orem, A., Cimşit, G., Uydu, H.A., Yandi, Y.E. and Alver, A., 2003. Plasma homocysteine and its relationship with atherothrombotic markers in psoriatic patients. Clinica Chimica Acta 332, 23–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2012 Wageningen Academic Publishers
About this chapter
Cite this chapter
Laing, M. (2012). Skin cancer and folate metabolism. In: Preedy, V.R. (eds) Handbook of diet, nutrition and the skin. Human Health Handbooks no. 1, vol 2. Wageningen Academic Publishers. https://doi.org/10.3920/978-90-8686-729-5_23
Download citation
DOI: https://doi.org/10.3920/978-90-8686-729-5_23
Publisher Name: Wageningen Academic Publishers
Online ISBN: 978-90-8686-729-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)